Back to discover
Disease
Vulvar Neoplasms
Late-stage therapeutic developmentEmerging research
2
Publications
5
Clinical trials
2024
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Research2024-03-01Journal of the National Comprehensive Cancer Network : JNCCN
Research2023-07-03International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial expected to report results, the earliest in Q1 2027.
Major developments
Upcoming trial readoutHigh impact
Results expected Q1 20272026-06-16
Major trial resultsImportant
Results posted2026-03-09
Clinical MilestonesViewHide
Results posted
Results expected
Recently completed
Activity timeline3
- 2026-07-01ClinicalPhase II Basket Study to Evaluate the Tissue-agnostic Efficacy of Anti-Programmed Cell Death Protein 1 (Anti-PD1) Monoclonal Antibody in Patients With Advanced Rare TumorsPrimary completion
- 2026-06-16ClinicalA Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal CancerResults expected Q1 2027
- 2026-03-09ClinicalA Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated CancersResults posted
Clinical trials
The current development programme across all trial phases.
Clinical programme
5
3
1
2
Late-stage studies
Recruiting
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
20232024
Most influential
Major themes3
- Vulvar Neoplasms2
- Gynecology1
- Plastic Surgery Procedures1
Leading journals2
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society1
- Journal of the National Comprehensive Cancer Network : JNCCN1
Leading researchers8
- Abu-Rustum NR1
- Arend R1
- Baldwin P1
- Barber E1
- Bradley K1
- Brooks R1
- Campos SM1
- Chino J1
Affiliations (unnormalised)6
- Abramson Cancer Center at the University of Pennsylvania.1
- Addenbrooke's Hospital1
- Almazov National Medical Research Center1
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.1
- Catholic University of the Sacred Heart1
- Charles University First Faculty of Medicine1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Tumors or cancer of the VULVA.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.